Clinical observation of imatinib combined with Hyper-CVAD in treatment of adults with Philadelphia chromosome positive acute lymphoblastic leukemia

Clinical Focus ›› 2015, Vol. 30 ›› Issue (6): 633-636.

Previous Articles Next Articles

Clinical observation of imatinib combined with Hyper-CVAD in treatment of adults with Philadelphia chromosome positive acute lymphoblastic leukemia

Wang Meimei;Zhu Weijian;Li Zhixin;Li Xiaoliang;Gong Wuxing

Online:2015-06-05 Published:2015-06-05

Abstract

CLC Number:

R733.1

Wang Meimei;Zhu Weijian;Li Zhixin;Li Xiaoliang;Gong Wuxing. Clinical observation of imatinib combined with Hyper-CVAD in treatment of adults with Philadelphia chromosome positive acute lymphoblastic leukemia[J]. Clinical Focus, 2015, 30(6): 633-636.

Add to citation manager EndNote|Ris|BibTeX

URL: https://huicui.hebmu.edu.cn/EN/

https://huicui.hebmu.edu.cn/EN/Y2015/V30/I6/633

[1]	Liu Xitinga, Wu Yuqianga, Chen Zeb. Shortterm and longterm curative effect of pemetrexed combined with carboplatin on advanced NSCLC [J]. Clinical Focus, 2020, 35(9): 837-840.
[2]	Lyu Cuicui, Li Xin, Li Qing, Mu Juan, Wang Jia, Yuan Ting, Jiang Yanyu, Deng Qi. Influence of TKIs on proliferation of CD19 CAR-T cells in refractory/relapsed Ph+ acute lymphoblastic leukemia [J]. Clinical Focus, 2020, 35(10): 909-913.

Clinical observation of imatinib combined with Hyper-CVAD in treatment of adults with Philadelphia chromosome positive acute lymphoblastic leukemia

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 2

Recommended Articles

Metrics

Comments